Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Advances in Brief

  • Advances in Brief
    Transforming Growth Factor-β1 Mediates Cellular Response to DNA Damage in Situ
    Kenneth B. Ewan, Rhonda L. Henshall-Powell, Shraddha A. Ravani, Maria Jose Pajares, Carlos Arteaga, Ray Warters, Rosemary J. Akhurst and Mary Helen Barcellos-Hoff
    Cancer Res October 15 2002 62 (20) 5627-5631;

  • Advances in Brief
    p300 Mediates Androgen-independent Transactivation of the Androgen Receptor by Interleukin 6
    Jose D. Debes, Lucy J. Schmidt, Haojie Huang and Donald J. Tindall
    Cancer Res October 15 2002 62 (20) 5632-5636;

  • Advances in Brief
    Hypermethylation of HPP1 Is Associated with hMLH1 Hypermethylation in Gastric Adenocarcinomas
    David M. Shibata, Fumiaki Sato, Yuriko Mori, Kellie Perry, Jing Yin, Suna Wang, Yan Xu, Andreea Olaru, Florin Selaru, Kevin Spring, Joanne Young, John M. Abraham and Stephen J. Meltzer
    Cancer Res October 15 2002 62 (20) 5637-5640;

  • Advances in Brief
    Hypermutable Bases in the p53 Cancer Gene Are at Vulnerable Positions in DNA Secondary Structures
    Barbara E. Wright, Jacqueline M. Reimers, Karen H. Schmidt and Dennis K. Reschke
    Cancer Res October 15 2002 62 (20) 5641-5644;

  • Advances in Brief
    Activated Mammalian Target of Rapamycin Pathway in the Pathogenesis of Tuberous Sclerosis Complex Renal Tumors
    Heidi L. Kenerson, Lauri D. Aicher, Lawrence D. True and Raymond S. Yeung
    Cancer Res October 15 2002 62 (20) 5645-5650;

  • Advances in Brief
    Isolation of a Novel Human Gene, APCDD1, as a Direct Target of the β-Catenin/T-Cell Factor 4 Complex with Probable Involvement in Colorectal Carcinogenesis
    Meiko Takahashi, Manabu Fujita, Yoichi Furukawa, Ryuji Hamamoto, Takashi Shimokawa, Nobutomo Miwa, Michio Ogawa and Yusuke Nakamura
    Cancer Res October 15 2002 62 (20) 5651-5656;

  • Advances in Brief
    The Use of Interleukin 12-secreting Neural Stem Cells for the Treatment of Intracranial Glioma
    Moneeb Ehtesham, Peter Kabos, Andrea Kabosova, Toomas Neuman, Keith L. Black and John S. Yu
    Cancer Res October 15 2002 62 (20) 5657-5663;

  • Advances in Brief
    Identical T-cell Receptor Transcripts in Multiple Melanoma Metastases
    David Schrama, Eva Fuchs, Eva-Bettina Bröcker, Per thor Straten and Jürgen C. Becker
    Cancer Res October 15 2002 62 (20) 5664-5667;

  • Advances in Brief
    A Novel Mechanism of Nuclear Factor κB Activation through the Binding between Inhibitor of Nuclear Factor-κBα and the Processed NH2-terminal Region of Mig-6
    Toshiyuki Tsunoda, Junichi Inokuchi, Iwai Baba, Koji Okumura, Seiji Naito, Takehiko Sasazuki and Senji Shirasawa
    Cancer Res October 15 2002 62 (20) 5668-5671;

Biochemistry and Biophysics

  • Biochemistry and Biophysics
    Measurement by Nuclear Magnetic Resonance Diffusion of the Dimensions of the Mobile Lipid Compartment in C6 Cells
    Yolanda Pérez, Hana Lahrech, Miquel E. Cabañas, Ramon Barnadas, Manel Sabés, Chantal Rémy and Carles Arús
    Cancer Res October 15 2002 62 (20) 5672-5677;

  • Biochemistry and Biophysics
    Sudan I Is a Potential Carcinogen for Humans
    Marie Stiborová, Václav Martínek, Helena Rýdlová, Petr Hodek and Eva Frei
    Cancer Res October 15 2002 62 (20) 5678-5684;

Carcinogenesis

  • Carcinogenesis
    Overexpression of Glutamine Synthetase Is Associated with β-Catenin-Mutations in Mouse Liver Tumors during Promotion of Hepatocarcinogenesis by Phenobarbital
    Sandra Loeppen, Daniela Schneider, Frank Gaunitz, Rolf Gebhardt, Raffael Kurek, Albrecht Buchmann and Michael Schwarz
    Cancer Res October 15 2002 62 (20) 5685-5688;

  • Carcinogenesis
    Ultraviolet-induced Phosphorylation of p70S6K at Thr389 and Thr421/Ser424 Involves Hydrogen Peroxide and Mammalian Target of Rapamycin but not Akt and Atypical Protein Kinase C
    Chuanshu Huang, Jingxia Li, Qingdong Ke, Stephen S. Leonard, Bing-Hua Jiang, Xiao-Song Zhong, Max Costa, Vincent Castranova and Xianglin Shi
    Cancer Res October 15 2002 62 (20) 5689-5697;

Clinical Investigations

  • Clinical Investigations
    Assessment of Proliferation in Vivo Using 2-[11C]Thymidine Positron Emission Tomography in Advanced Intra-abdominal Malignancies
    Paula Wells, Roger N. Gunn, Malcolm Alison, Colin Steel, Mathew Golding, Alex S. Ranicar, Frank Brady, Safiye Osman, Terry Jones and Pat Price
    Cancer Res October 15 2002 62 (20) 5698-5702;

Experimental Therapeutics

  • Experimental Therapeutics
    Enhanced Sensitization to Taxol-induced Apoptosis by Herceptin Pretreatment in ErbB2-overexpressing Breast Cancer Cells
    Sangkyou Lee, Wentao Yang, Keng-Hsueh Lan, Shankar Sellappan, Kristine Klos, Gabriel Hortobagyi, Mien-Chie Hung and Dihua Yu
    Cancer Res October 15 2002 62 (20) 5703-5710;

  • Experimental Therapeutics
    Benzylamide Sulindac Analogues Induce Changes in Cell Shape, Loss of Microtubules and G2-M Arrest in a Chronic Lymphocytic Leukemia (CLL) Cell Line and Apoptosis in Primary CLL Cells
    Eun-Yi Moon and Adam Lerner
    Cancer Res October 15 2002 62 (20) 5711-5719;

  • Experimental Therapeutics
    Inhibition of Growth and Metastasis of Orthotopic Human Prostate Cancer in Athymic Mice by Combination Therapy with Pegylated Interferon-α-2b and Docetaxel
    Samuel F. Huang, Sun-Jin Kim, Anh T. Lee, Takashi Karashima, Cora Bucana, Daniel Kedar, Paul Sweeney, Badar Mian, Dominic Fan, David Shepherd, Isaiah J. Fidler, Colin P. Dinney and Jerald J. Killion
    Cancer Res October 15 2002 62 (20) 5720-5726;

  • Experimental Therapeutics
    Combined Therapy of Local and Metastatic 4T1 Breast Tumor in Mice Using SU6668, an Inhibitor of Angiogenic Receptor Tyrosine Kinases, and the Immunostimulator B7.2-IgG Fusion Protein
    Xiaojun Huang, Michael K. Wong, Huiming Yi, Simon Watkins, A. Douglas Laird, Stanley F. Wolf and Elieser Gorelik
    Cancer Res October 15 2002 62 (20) 5727-5735;

  • Experimental Therapeutics
    Potential of the Conditionally Replicative Adenovirus Ad5-Δ24RGD in the Treatment of Malignant Gliomas and Its Enhanced Effect with Radiotherapy
    Martine L. M. Lamfers, Jacques Grill, Clemens M. F. Dirven, Victor W. van Beusechem, Birgit Geoerger, Jaap van den Berg, Ramon Alemany, Juan Fueyo, David T. Curiel, Gilles Vassal, Herbert M. Pinedo, W. Peter Vandertop and Winald R. Gerritsen
    Cancer Res October 15 2002 62 (20) 5736-5742;

  • Experimental Therapeutics
    UCN-01 Inhibits p53 Up-Regulation and Abrogates γ-Radiation-induced G2-M Checkpoint Independently of p53 by Targeting Both of the Checkpoint Kinases, Chk2 and Chk1
    Qiang Yu, JiHyun La Rose, Hongliang Zhang, Haruyuki Takemura, Kurt W. Kohn and Yves Pommier
    Cancer Res October 15 2002 62 (20) 5743-5748;

  • Experimental Therapeutics
    ZD1839 (Iressa)
    Alan E. Wakeling, Simon P. Guy, Jim R. Woodburn, Susan E. Ashton, Brenda J. Curry, Andrew J. Barker and Keith H. Gibson
    Cancer Res October 15 2002 62 (20) 5749-5754;

  • Experimental Therapeutics
    Radioimmunotherapy of A431 Xenografted Mice with Pretargeted B3 Antibody-Streptavidin and 90Y-labeled 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-tetraacetic Acid (DOTA)-Biotin
    Zhengsheng Yao, Meili Zhang, Donald B. Axworthy, Karen J. Wong, Kayhan Garmestani, Luke Park, Chang W. Park, Robert W. Mallett, Louis J. Theodore, Eric K. Yau, Thomas A. Waldmann, Martin W. Brechbiel, Chang H. Paik, Ira Pastan and Jorge A. Carrasquillo
    Cancer Res October 15 2002 62 (20) 5755-5760;

  • Experimental Therapeutics
    Molecular Characterization and Sensitivity of STI-571 (Imatinib Mesylate, Gleevec)-resistant, Bcr-Abl-positive, Human Acute Leukemia Cells to SRC Kinase Inhibitor PD180970 and 17-Allylamino-17-demethoxygeldanamycin
    Ramadevi Nimmanapalli, Erica O’Bryan, Mei Huang, Purva Bali, Pearlie Kay Burnette, Thomas Loughran, James Tepperberg, Richard Jove and Kapil Bhalla
    Cancer Res October 15 2002 62 (20) 5761-5769;

  • Experimental Therapeutics
    Vector-based Vaccine/Cytokine Combination Therapy to Enhance Induction of Immune Responses to a Self-Antigen and Antitumor Activity
    Wilhelmina M. Aarts, Jeffrey Schlom and James W. Hodge
    Cancer Res October 15 2002 62 (20) 5770-5777;

  • Experimental Therapeutics
    Cyclooxygenase-2 Inhibition with Celecoxib Enhances Antitumor Efficacy and Reduces Diarrhea Side Effect of CPT-11
    Ovidiu C. Trifan, William F. Durham, Valerie S. Salazar, Jennifer Horton, Benjamin D. Levine, Ben S. Zweifel, Thomas W. Davis and Jaime L. Masferrer
    Cancer Res October 15 2002 62 (20) 5778-5784;

Immunology

  • Immunology
    Visualization of Effective Tumor Targeting by CD8+ Natural Killer T Cells Redirected with Bispecific Antibody F(ab′)2HER2xCD3
    Christian Scheffold, Martin Kornacker, Yolanda C. Scheffold, Christopher H. Contag and Robert S. Negrin
    Cancer Res October 15 2002 62 (20) 5785-5791;

  • Immunology
    Establishment of an HLA-A*0201 Human Papillomavirus Type 16 Tumor Model to Determine the Efficacy of Vaccination Strategies in HLA-A*0201 Transgenic Mice
    Gretchen L. Eiben, Markwin P. Velders, Hans Schreiber, Maria Cristina Cassetti, Jeffrey K. Pullen, Larry R. Smith and W. Martin Kast
    Cancer Res October 15 2002 62 (20) 5792-5799;

  • Immunology
    Effects of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Alone and in Combination with Chemotherapeutic Agents on Patients’ Colon Tumors Grown in SCID Mice
    Takuji Naka, Kenji Sugamura, Bonnie L. Hylander, Michael B. Widmer, Youcef M. Rustum and Elizabeth A. Repasky
    Cancer Res October 15 2002 62 (20) 5800-5806;

  • Immunology
    Recognition of Prostate Tumor Cells by Cytotoxic T Lymphocytes Specific for Prostate-specific Membrane Antigen
    Jun Lu and Esteban Celis
    Cancer Res October 15 2002 62 (20) 5807-5812;

  • Immunology
    Impaired Antibody-dependent Cellular Cytotoxicity Mediated by Herceptin in Patients with Gastric Cancer
    Koji Kono, Akihiro Takahashi, Fumiko Ichihara, Hidemitsu Sugai, Hideki Fujii and Yoshirou Matsumoto
    Cancer Res October 15 2002 62 (20) 5813-5817;

  • Immunology
    Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines
    Toni Weinschenk, Cécile Gouttefangeas, Markus Schirle, Florian Obermayr, Steffen Walter, Oliver Schoor, Raffael Kurek, Wolfgang Loeser, Karl-Horst Bichler, Dorothee Wernet, Stefan Stevanović and Hans-Georg Rammensee
    Cancer Res October 15 2002 62 (20) 5818-5827;

  • Immunology
    Susceptibility to Lymphoid Neoplasia in Immunodeficient Strains of Nonobese Diabetic Mice
    Priscilla P. L. Chiu, Evgueni Ivakine, Steven Mortin-Toth and Jayne S. Danska
    Cancer Res October 15 2002 62 (20) 5828-5834;

  • Immunology
    Direct Detection and Quantitation of a Distinct T-Cell Epitope Derived from Tumor-specific Epithelial Cell-associated Mucin Using Human Recombinant Antibodies Endowed with the Antigen-specific, Major Histocompatibility Complex-restricted Specificity of T Cells
    Cyril J. Cohen, Noa Hoffmann, Marganit Farago, Hennie R. Hoogenboom, Lea Eisenbach and Yoram Reiter
    Cancer Res October 15 2002 62 (20) 5835-5844;

  • Immunology
    Immunogenicity of a Plasmid DNA Vaccine Encoding Chimeric Idiotype in Patients with B-Cell Lymphoma
    John M. Timmerman, Gita Singh, Gary Hermanson, Peter Hobart, Debra K. Czerwinski, Behnaz Taidi, Ranjani Rajapaksa, Clemens B. Caspar, Adrienne van Beckhoven and Ronald Levy
    Cancer Res October 15 2002 62 (20) 5845-5852;

  • Immunology
    Interleukin 18 Gene Transfer Expands the Repertoire of Antitumor Th1-type Immunity Elicited by Dendritic Cell-based Vaccines in Association with Enhanced Therapeutic Efficacy
    Tomohide Tatsumi, Andrea Gambotto, Paul D. Robbins and Walter J. Storkus
    Cancer Res October 15 2002 62 (20) 5853-5858;

Molecular Biology and Genetics

  • Molecular Biology and Genetics
    Genome-wide Analysis of Gene Expression in Synovial Sarcomas Using a cDNA Microarray
    Satoshi Nagayama, Toyomasa Katagiri, Tatsuhiko Tsunoda, Taisuke Hosaka, Yasuaki Nakashima, Nobuhito Araki, Katsuyuki Kusuzaki, Tomitaka Nakayama, Tadao Tsuboyama, Takashi Nakamura, Masayuki Imamura, Yusuke Nakamura and Junya Toguchida
    Cancer Res October 15 2002 62 (20) 5859-5866;

  • Molecular Biology and Genetics
    Comparative Gene Expression Profile Analysis of GLI and c-MYC in an Epithelial Model of Malignant Transformation
    Iúri D. Louro, Evans C. Bailey, Xingnan Li, Lindsey S. South, Peggy R. McKie-Bell, Bradley K. Yoder, Conway C. Huang, Martin R. Johnson, Aubrey E. Hill, Ronald L. Johnson and J. Michael Ruppert
    Cancer Res October 15 2002 62 (20) 5867-5873;

  • Molecular Biology and Genetics
    SLIT2, a Human Homologue of the Drosophila Slit2 Gene, Has Tumor Suppressor Activity and Is Frequently Inactivated in Lung and Breast Cancers
    Ashraf Dallol, Nancy Fernandes Da Silva, Paolo Viacava, John D. Minna, Ivan Bieche, Eamonn R. Maher and Farida Latif
    Cancer Res October 15 2002 62 (20) 5874-5880;

  • Molecular Biology and Genetics
    High Expression of Inducible 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase (iPFK-2; PFKFB3) in Human Cancers
    Toshiya Atsumi, Jason Chesney, Christine Metz, Lin Leng, Seamas Donnelly, Zenji Makita, Robert Mitchell and Richard Bucala
    Cancer Res October 15 2002 62 (20) 5881-5887;

  • Molecular Biology and Genetics
    An Antisense Oligonucleotide Targeted to Human Ku86 Messenger RNA Sensitizes M059K Malignant Glioma Cells to Ionizing Radiation, Bleomycin, and Etoposide but not DNA Cross-Linking Agents
    Alexandre I. Belenkov, Jean-Pierre Paiement, Lawrence C. Panasci, Brett P. Monia and Terry Y. K. Chow
    Cancer Res October 15 2002 62 (20) 5888-5896;

  • Molecular Biology and Genetics
    Deregulation of Caspase 8 and 10 Expression in Pediatric Tumors and Cell Lines
    Kenichi Harada, Shinichi Toyooka, Narayan Shivapurkar, Anirban Maitra, Jyotsna L. Reddy, Hittu Matta, Kuniharu Miyajima, Charles F. Timmons, Gail E. Tomlinson, Domenico Mastrangelo, Robert J. Hay, Preet M. Chaudhary and Adi F. Gazdar
    Cancer Res October 15 2002 62 (20) 5897-5901;

  • Molecular Biology and Genetics
    Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer
    Manel Esteller, Mingzhou Guo, Victor Moreno, Miquel Angel Peinado, Gabriel Capella, Oliver Galm, Stephen B. Baylin and James G. Herman
    Cancer Res October 15 2002 62 (20) 5902-5905;

  • Molecular Biology and Genetics
    Biallelic Epigenetic Inactivation of the RASSF1A Tumor Suppressor Gene in Medulloblastoma Development
    Meryl E. Lusher, Janet C. Lindsey, Farida Latif, Andrew D. J. Pearson, David W. Ellison and Steven C. Clifford
    Cancer Res October 15 2002 62 (20) 5906-5911;

Tumor Biology

  • Tumor Biology
    The Development of [124I]Iodinated-VG76e
    David R. Collingridge, Veronica A. Carroll, Mathias Glaser, Eric O. Aboagye, Safiye Osman, Oliver C. Hutchinson, Henryk Barthel, Sajinder K. Luthra, Frank Brady, Roy Bicknell, Pat Price and Adrian L. Harris
    Cancer Res October 15 2002 62 (20) 5912-5919;

  • Tumor Biology
    Identification of the Human PHLDA1/TDAG51 Gene
    Rüdiger Neef, Martina A. Kuske, Elma Pröls and Judith P. Johnson
    Cancer Res October 15 2002 62 (20) 5920-5929;

  • Tumor Biology
    Multiple Actions of the Chemokine CXCL12 on Epithelial Tumor Cells in Human Ovarian Cancer
    Chris J. Scotton, Julia L. Wilson, Kate Scott, Gordon Stamp, George D. Wilbanks, Simon Fricker, Gary Bridger and Frances R. Balkwill
    Cancer Res October 15 2002 62 (20) 5930-5938;

  • Tumor Biology
    Dissecting Karyotypic Patterns in Colorectal Tumors
    Mattias Höglund, David Gisselsson, Gunnar B. Hansen, Torbjörn Säll, Felix Mitelman and Mef Nilbert
    Cancer Res October 15 2002 62 (20) 5939-5946;

  • Tumor Biology
    PML Is a Target Gene of β-Catenin and Plakoglobin, and Coactivates β-Catenin-mediated Transcription
    Michael Shtutman, Jacob Zhurinsky, Moshe Oren, Elina Levina and Avri Ben-Ze’ev
    Cancer Res October 15 2002 62 (20) 5947-5954;

  • Tumor Biology
    Compound Disruption of Smad2 Accelerates Malignant Progression of Intestinal Tumors in Apc Knockout Mice
    Toshiaki Hamamoto, Hideyuki Beppu, Hitoshi Okada, Masahiro Kawabata, Tadaichi Kitamura, Kohei Miyazono and Mitsuyasu Kato
    Cancer Res October 15 2002 62 (20) 5955-5961;

  • Tumor Biology
    Down-Regulation of COOH-Terminal Binding Protein Expression in Malignant Melanomas Leads to Induction of MIA Expression
    Ina Poser, Michaela Golob, Michael Weidner, Reinhard Buettner and Anja K. Bosserhoff
    Cancer Res October 15 2002 62 (20) 5962-5966;

  • Tumor Biology
    Organ Heterogeneity of Host-derived Matrix Metalloproteinase Expression and Its Involvement in Multiple-Organ Metastasis by Lung Cancer Cell Lines
    Minoru Shiraga, Seiji Yano, Akihiko Yamamoto, Hirohisa Ogawa, Hisatsugu Goto, Toyokazu Miki, Keisuke Miki, Helong Zhang and Saburo Sone
    Cancer Res October 15 2002 62 (20) 5967-5973;

  • Tumor Biology
    Preoperative Blood Reverse Transcriptase-PCR Assays for Prostate-specific Antigen and Human Glandular Kallikrein for Prediction of Prostate Cancer Progression after Radical Prostatectomy
    Shahrokh F. Shariat, Emanuel Gottenger, Cuong Nguyen, Weitao Song, Michael W. Kattan, John Andenoro, Thomas M. Wheeler, David M. Spencer and Kevin M. Slawin
    Cancer Res October 15 2002 62 (20) 5974-5979;

  • Tumor Biology
    Genome-wide Allelotyping of a New in Vitro Model System Reveals Early Events in Breast Cancer Progression
    Zheng Li, Zhen Hang Meng, Aejaz Sayeed, Refaat Shalaby, Britt-Marie Ljung and Shanaz H. Dairkee
    Cancer Res October 15 2002 62 (20) 5980-5987;

Letters to the Editor

  • Letters to the Editor
    Correspondence re: P. Laiho et al., Low-Level Microsatellite Instability in Most Colorectal Carcinomas. Cancer Res., 62: 1166–1170, 2002.
    Jeremy R. Jass, Vicki L. J. Whitehall, Joanne Young, Barbara Leggett, Stephen J. Meltzer, Nagahide Matsubara and Richard Fishel
    Cancer Res October 15 2002 62 (20) 5988-5990;

  • Erratum
    Cancer Res October 15 2002 62 (20) 5992-5992;

Back to top
PreviousNext
Cancer Research: 62 (20)
October 2002
Volume 62, Issue 20
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • The Use of Interleukin 12-secreting Neural Stem Cells for the Treatment of Intracranial Glioma
  • Compound Disruption of Smad2 Accelerates Malignant Progression of Intestinal Tumors in Apc Knockout Mice
  • PML Is a Target Gene of β-Catenin and Plakoglobin, and Coactivates β-Catenin-mediated Transcription

Jump to

  • Advances in Brief
  • Biochemistry and Biophysics
  • Carcinogenesis
  • Clinical Investigations
  • Experimental Therapeutics
  • Immunology
  • Molecular Biology and Genetics
  • Tumor Biology
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • Towards Multidrug Adaptive Therapy
  • MEK Inhibition Synergizes with Statins for Cancer Treatment
  • IL1β Promotes Immune Suppression in Pancreatic Cancer
  • Multiple Primary Cancer Penetrance for TP53
  • Metabolomic Gradients in Glioblastoma Models
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement